Related Experiment Videos
Gaucher disease--Norrbottnian type. I. General clinical description
European Journal of Pediatrics
|March 1, 1980
Summary
Follow-up studies of Norrbottnian Gaucher disease (type III) reveal genetic homogeneity within families but varied disease severity. Splenectomy worsened skeletal and central nervous system symptoms.
Area of Science:
- Medical Genetics
- Rare Diseases
- Neurology
Background:
- Gaucher disease is a lysosomal storage disorder.
- The Norrbottnian type (type III) is a specific subtype of Gaucher disease.
- Previous studies suggest a unique genetic origin for this subtype.
Purpose of the Study:
- To conduct follow-up studies on 22 cases of Norrbottnian Gaucher disease.
- To investigate genotype-phenotype correlations and disease progression.
- To explore the impact of splenectomy on disease course.
Main Methods:
- Retrospective analysis of 22 patients with Norrbottnian Gaucher disease.
- Classification of patients based on birth province (Norrbotten, Västerbotten).
- Clinical assessment of organ manifestations, complications, and disease severity.
Main Results:
- No significant differences in organ manifestations or complications between the two family groups.
- Marked variability in clinical symptoms and disease course, even among siblings.
- Splenectomy was associated with accelerated deterioration, especially in skeletal and central nervous system involvement.
Conclusions:
- The Norrbottnian type of Gaucher disease appears genotypically homogeneous within families.
- Disease severity and progression exhibit significant inter- and intra-familial variability.
- Splenectomy is contraindicated as it exacerbates disease manifestations in this specific Gaucher disease type.